טוען...

Association Between Disease-Free Survival and Overall Survival When Survival Is Prolonged After Recurrence in Patients Receiving Cytotoxic Adjuvant Therapy for Colon Cancer: Simulations Based on the 20,800 Patient ACCENT Data Set

PURPOSE: We previously validated disease-free survival (DFS) as a surrogate for overall survival (OS) in fluorouracil-based adjuvant colon cancer clinical trials. New therapies have extended survival after recurrence from 1 to approximately 2 years. We examined the possible impact of this improvemen...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: de Gramont, Aimery, Hubbard, Joleen, Shi, Qian, O'Connell, Michael J., Buyse, Marc, Benedetti, Jacqueline, Bot, Brian, O'Callaghan, Chris, Yothers, Greg, Goldberg, Richard M., Blanke, Charles D., Benson, Al, Deng, Qiqi, Alberts, Steven R., Andre, Thierry, Wolmark, Norman, Grothey, Axel, Sargent, Daniel
פורמט: Artigo
שפה:Inglês
יצא לאור: American Society of Clinical Oncology 2010
נושאים:
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC2815708/
https://ncbi.nlm.nih.gov/pubmed/20008641
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2009.23.1407
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!